1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. APELLIS PHARMACEUTICALS INC
Apellis Pharmaceuticals Inc
XNAS: APLS

Apellis Pharma Inc Live Stock Price Today, Share Analysis and Chart

Expensive Rocket
about

Apellis Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel therapeutic compounds to treat diseases with high unmet needs through the inhibition of the complement s...

Read More
40.69 -0.01 (-0.02%)
New 52W High in past week
4.6M
XNAS Volume

XNAS 08 Apr, 2026 5:30 PM (EDT)

Watchlist

Portfolio

Alert
Durability score
Medium Financial Strength
50.0 / 100
Valuation Score
Expensive Valuation
29.2 / 100
Momentum Score
Technically Moderately Bullish
67.4 / 100
Expensive Rocket These stocks have good momentum, but are expensive with average financials View Similar Embed DVM
Analyst Price Target
40
1Yr Price target downside is -2%
15 analysts

17

S

9

W

5

O

0

T

SWOT Analysis

Apellis Pharma Inc Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..